Belgium· BE-AMP-SAM394712-00

Oxaliplatine Ebewe Pharma 5 mg/ml

A oxaliplatin product containing oxaliplatin, registered in Belgium by Ebewe Pharma GesmbH Nfg KG. The same ATC class is registered in 17 of our 19 countries.

ATC L01XA03

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about oxaliplatinAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Oxaliplatin is registered in 17 of 19 countries.

Countries holding a registration under ATC L01XA03 (oxaliplatin), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
9 of them publish a price we can compare per daily dose

Search oxaliplatin products by name

Oxaliplatin · ATC L01XA03

17 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of oxaliplatin costs, country by country.

Normalised to the WHO defined daily dose (11 mg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Oxaliplatin · price per daily dose (11 mg)

USD · FX 28 Sept 2026

CH Switzerland$24.21

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Oxaliplatin
Manufacturer: Ebewe Pharma GesmbH Nfg KG
Country: Belgium (BE)
ATC code: L01XA03
ATC class: Oxaliplatin
Defined daily dose: 11 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

740 interactions on record for oxaliplatin.

Graded by severity as the source publishes them — 101 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check oxaliplatin against other medicines How interaction checks work

Oxaliplatin · interactions on record

740 records

101 severe
453 moderate
1 minor
185 info

Most severe, free to view

PapaverineA03AD01severe
CisaprideA03FA02severe
DolasetronA04AA04severe
QuinidineC01BA01severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Oxaliplatin in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All oxaliplatin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Ebeoxal, Oxaliplatin Accord
Bulgaria · Оксалиплатин Акорд, Оксалиплатин Булгермед
Cyprus · Oxaliplatin
Czechia · Oxaliplatin Accord, Oxaliplatin Agmed
Germany · Eloxatin, Medoxa
Denmark · Oxaliplatin Accord, Oxaliplatin Actavis
Estonia · Oxaliplatin Accord, Oxaliplatin Kabi
Spain · Oxaliplatino Accord, Oxaliplatino Aurovit
Finland · Oxaliplatin Accord
France · Dacplat, Eloxatine
United Kingdom (Northern Ireland) · Oxaliplatin Accord Healthcare, Oxaliplatin Amarox
Greece · Elatofen, Oxaliplatin Deltapharma
Croatia · Oksaliplatin Kalceks, Oxaliplatin Kabi
Hungary · Oxaliplatin Accord, Oxaliplatin Kabi
Ireland · Oxaliplatin Accord Healthcare Ireland, Oxaliplatin Fresenius Kabi Deutschland
Iceland · Oxaliplatin Actrevo, Oxaliplatin Teva
Italy · Oxaliplatino Accord, Oxaliplatino Aurobindo
Lithuania · Oxaliplatin Accord, Oxaliplatin Kabi
Luxembourg · Eloxatin, Oxaliplatine Fresenius Kabi
Latvia · Oxaliplatin Accord, Oxaliplatin Kabi
Malta · Oxaviatin
Netherlands · Oxaliplatin Hikma, Oxaliplatine Accord
Norway · Oksaliplatin Sun, Oxaliplatin Fresenius Kabi
Poland · Oxaliplatin Ebewe, Oxaliplatin Eugia
Portugal · Oxaliplatina Accord, Oxaliplatina Aurovitas
Romania · Oxaliplatin Accord, Oxaliplatin Aqvida Gmbh
Sweden · Oxaliplatin Accord, Oxaliplatin Eugia
Slovenia · Oksaliplatin Kabi, Oksaliplatin Sandoz
Slovakia · Oxaliplatin Agmed, Oxaliplatin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/5f8d2643-ccb3-4721-afd4-33b865493301
GET /v1/drugs/5f8d2643-ccb3-4721-afd4-33b865493301?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for concentrate for solution for infusion",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Oxaliplatine Ebewe Pharma 5 mg/ml",
  "name_fr": "Oxaliplatine Ebewe Pharma 5 mg/ml",
  "name_nl": "Oxaliplatine Ebewe Pharma 5 mg/ml",
  "amp_code": "SAM394712-00",
  "strengths": [
    "150.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Oxaliplatin"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Oxaliplatin",
  "authorisation_numbers": [
    "BE394721",
    "BE394737"
  ]
}

API reference MCP server Plans

See everything about oxaliplatin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console